RxDoctor Payments Data

Brian Lustgarten

Medical · van Nuys, CANPI 1326106683

Payments from drug & device makers

$162in general payments, 2019–2025

Across 7 payments — averaging $23.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$48
  • Pfizer$28
  • Boston Scientific$24
  • Abbott$23
  • Vertex$19
  • Zimmer Biomet$19

What the payments were for

  • Food & beverage$162100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen2$48
Pfizer1$28
Boston Scientific1$24
Abbott1$23
Vertex1$19
Zimmer Biomet1$19

How this compares

$162 in reported general payments places this provider in the 30th percentile of 2,087 medical providers in California.

See all medical providers in California

Medicare billing

Part B allowed, 2024
$153,085
Medicare patients
482
Services billed
1,597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin18$245
Tramadol Hcl76$171
Meloxicam12$34

Paid to pharmacies, not to this prescriber.

Other medical in van Nuys

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →